Acanthamoeba keratitis (AK) is a rare but devastating eye infection caused by a free-living amoeba found in water and soil.
Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The ...
Introduction Visual Hallucinations (VHs) (seeing things that others do not, or visions) are a common feature of psychosis, causing significant distress and disability. Services rarely ask about these ...
Asianet Newsable on MSN
OCGN stock rises pre-market after gene therapy data shows promise in rare eye disorder
Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe ...
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
Red light therapy is an emerging treatment for certain types of hair loss. Dermatologists explain how it works, when to use ...
The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
LYNX-3, the second pivotal Phase 3 trial in keratorefractive participants with visual disturbances under mesopic, low-contrast conditions, is ongoing with topline results expected in the first half of ...
SAN RAFAEL, CA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Rising Star Optometry is marking nearly two decades of continued service in the region, reflecting its long-term role in providing ...
The FDA granted breakthrough therapy designation to privosegtor, a novel peptoid small molecule for the treatment of optic ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback